Companies › COYA

COYA THERAPEUTICS INC (COYA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001835022 · EDGAR filings · Updated 2026-07-27

COYA THERAPEUTICS INC (COYA) has reported institutional ownership of 34.6%, with 57 institutional managers holding positions valued at $32.0M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-25 — Current report (8-K) filed
• 2026-05-13 — ARS filed
• 2026-05-13 — DEFA14A filed
• 2026-05-13 — Proxy statement (DEF 14A) filed
• 2026-05-12 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, COYA THERAPEUTICS INC has 57 institutional holders and institutional ownership of 34.6%.

Insider activity

Insiders reported 1 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

LIFEVANTAGE CORP (LFVN) · CELLECTIS S A (CLLS) · CONNECT BIOPHARMA HLDGS LTD (CNTB) · COMPUGEN LTD (CGEN) · AGENUS INC (AGEN) · LENSAR INC (LNSR)